1. Home
  2. GLMD vs DUO Comparison

GLMD vs DUO Comparison

Compare GLMD & DUO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Galmed Pharmaceuticals Ltd.

GLMD

Galmed Pharmaceuticals Ltd.

HOLD

Current Price

$0.86

Market Cap

6.6M

Sector

Health Care

ML Signal

HOLD

DUO

Fangdd Network Group Ltd.

HOLD

Current Price

$1.66

Market Cap

7.5M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
GLMD
DUO
Founded
2000
2011
Country
Israel
China
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Real Estate
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
6.6M
7.5M
IPO Year
2014
2019

Fundamental Metrics

Financial Performance
Metric
GLMD
DUO
Price
$0.86
$1.66
Analyst Decision
Hold
Analyst Count
1
0
Target Price
N/A
N/A
AVG Volume (30 Days)
184.4K
114.5K
Earning Date
11-26-2025
03-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$56,189,313.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
48.30
52 Week Low
$0.74
$1.24
52 Week High
$3.61
$11.84

Technical Indicators

Market Signals
Indicator
GLMD
DUO
Relative Strength Index (RSI) 35.20 41.07
Support Level $0.95 $1.86
Resistance Level $0.99 $2.44
Average True Range (ATR) 0.09 0.16
MACD -0.01 -0.02
Stochastic Oscillator 11.25 7.15

Price Performance

Historical Comparison
GLMD
DUO

About GLMD Galmed Pharmaceuticals Ltd.

Galmed Pharmaceuticals Ltd is a biopharmaceutical company. It focuses on the development of Aramchol. exclusively on developing Aramchol for the treatment of liver disease and were previously developing Aramchol for primary sclerosing cholangitis, PSC, and exploring the feasibility of developing Aramchol for other fibro-inflammatory indications outside of NASH and fibrosis. The company is currently seeking to advance the development of Aramchol for oncological indications outside of NASH and fibrosis.

About DUO Fangdd Network Group Ltd.

Fangdd Network Group Ltd is an investment holding company. It is engaged in the provision of real estate information services through its online platform which also offers integrated marketing services for individual customers, real estate developers, and agents in China. Its SaaS-based solutions help real estate agents to connect with essential business resources, including customers, property listings, capital, and transaction data. The company generates the majority of its revenue from Base commission from transactions in China.

Share on Social Networks: